FY2026 EPS Estimates for Owens & Minor Lowered by Analyst

Owens & Minor, Inc. (NYSE:OMI) – Equities researchers at Leerink Partnrs dropped their FY2026 earnings estimates for Owens & Minor in a note issued to investors on Thursday, February 20th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $1.95 for the year, down from their prior estimate of $1.97. The consensus estimate for Owens & Minor’s current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor’s FY2027 earnings at $2.33 EPS.

Several other research firms also recently issued reports on OMI. Barclays decreased their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Citigroup decreased their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. UBS Group dropped their price target on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Finally, Robert W. Baird reduced their price objective on Owens & Minor from $15.00 to $14.00 and set a “neutral” rating for the company in a research note on Tuesday, February 4th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Owens & Minor currently has an average rating of “Hold” and a consensus target price of $16.79.

Owens & Minor Trading Down 6.8 %

Shares of Owens & Minor stock opened at $6.38 on Friday. The company has a fifty day simple moving average of $12.22 and a 200-day simple moving average of $13.59. Owens & Minor has a 12-month low of $6.30 and a 12-month high of $28.35. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The stock has a market cap of $491.72 million, a price-to-earnings ratio of -9.81, a PEG ratio of 0.21 and a beta of 0.48.

Institutional Trading of Owens & Minor

Hedge funds have recently added to or reduced their stakes in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Owens & Minor by 29.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 219,761 shares of the company’s stock worth $2,872,000 after purchasing an additional 50,184 shares during the last quarter. Voloridge Investment Management LLC lifted its stake in shares of Owens & Minor by 24.2% in the 4th quarter. Voloridge Investment Management LLC now owns 243,525 shares of the company’s stock worth $3,183,000 after acquiring an additional 47,459 shares during the period. Squarepoint Ops LLC purchased a new stake in shares of Owens & Minor in the fourth quarter valued at about $381,000. State of Wyoming increased its stake in shares of Owens & Minor by 35.3% during the fourth quarter. State of Wyoming now owns 23,198 shares of the company’s stock worth $303,000 after acquiring an additional 6,050 shares during the period. Finally, ProShare Advisors LLC increased its stake in shares of Owens & Minor by 44.5% during the fourth quarter. ProShare Advisors LLC now owns 22,702 shares of the company’s stock worth $297,000 after acquiring an additional 6,996 shares during the period. 98.04% of the stock is owned by institutional investors and hedge funds.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.